Introduction
============

Neonatal respiratory distress syndrome (NRDS), also termed hyaline membrane disease, is one of the most prevalent causes of morbidity and mortality in newborns ([@b1-mmr-17-01-0059]). The oxygen diffusion efficiency through the alveoli-capillary exchange barrier is impacted by the dysregulation of numerous factors, leading to the pathophysiology of NRDS ([@b2-mmr-17-01-0059]). Cellular stress at the gas-blood level is associated with alterations in alveolar surfactant proteins ([@b3-mmr-17-01-0059]) and the upregulation of numerous innate immune responses of pro-inflammatory cytokines to foreign challenges ([@b4-mmr-17-01-0059]). A lack of surfactant may drive the pathogenesis towards NRDS, while surfactant replacement therapy may mitigate symptoms of the disease by decreasing the surface tension of alveoli and facilitating their inflation ([@b5-mmr-17-01-0059],[@b6-mmr-17-01-0059]). However, surfactant serves an additional role in immunological processes. A recent study demonstrated that applying clinical surfactant for patients led to a stronger response to challenges from foreign microbiota ([@b7-mmr-17-01-0059]). Additionally, animal-derived surfactant applied for clinical use in humans has been demonstrated to be of use against lung pathogens and to mediate excess host damage from neutrophils ([@b8-mmr-17-01-0059]). Therefore, it may be hypothesized that mechanisms that mechanisms of NRDS involving surfactant exert additional functions to promoting alveolar inflation.

Acute respiratory distress syndrome (ARDS) is a clinical phenotype precipitated by the manifestation of a severe form of lung injury due to numerous lung insults ([@b9-mmr-17-01-0059]). The pathophysiological manifestation of ARDS is derived from a cascade that is triggered by the complex combination of risk factors, including asthma, sepsis, pneumonia, increased neutrophil presence in the lungs and other variables; accumulation of these numerous systemic factors forms the pathological endpoint of ARDS ([@b10-mmr-17-01-0059]).

The present study used peripheral blood obtained from infants with (n=4) or without (n=2) NRDS in tandem with mRNA-sequencing (mRNA-seq) analysis to reveal various factors involved in the mechanisms of NRDS, and to compare onset mechanisms between NRDS and ARDS.

Materials and methods
=====================

### Samples

The Ethics Committee of the Affiliated Hospital of Inner Mongolia Medical University (Huhehaote, China) approved the present study. All study participants provided written informed consent and were recruited at the Affiliated Hospital of Inner Mongolia Medical University between January 1 and June 30, 2016.

A total of four infants with severe NRDS and two healthy infants were recruited for the present study. Subject characteristics are presented in [Table I](#tI-mmr-17-01-0059){ref-type="table"}. The subjects were not related, and all of their relatives in the three most recent generations were residents in Inner Mongolia province and self-identified as Chinese Inner Mongolia race. NRDS was diagnosed according to the European Consensus Guidelines on the Diagnosis of NRDS in Preterm Infants 2010 ([@b11-mmr-17-01-0059]). The criteria were as follows: Progressive deterioration of shortness of breath commencing at 12 h post-birth, with arterial partial pressure of oxygen (PaO~2~) \<50 mmHg during inspiration accompanied by central cyanosis. Oxygen therapy was required to maintain PaO~2~ \>50 mmHg. Chest X-ray (CXR) indicated NRDS specific signs, including ground glass opacity and air-filled bronchi. The control groups were defined by CXR demonstrating clear lung field without pulmonary infection signs. White blood cell counts and C-reactive protein values were normal, to exclude the possibility of any infection. Subjects with any of the following were excluded from the present study: i) Any serious congenital diseases, including complex congenital cardiac anomaly or diaphragm hernia; ii) inherited metabolic disorders, including phenylketonuria, congenital hypothyroidism or diabetes mellitus; iii) confirmed maternal infection history during the third trimester of pregnancy; iv) multigestation; v) maternal diabetes mellitus; or vi) neonatal asphyxia.

### mRNA extraction and sequencing

Total RNAs from 4 NRDS and 2 control subjects were isolated and quality controlled using protocols from Illumina, Inc. (San Diego, CA, USA). A total amount of 3 µg RNA/sample was used as the input material for library construction. Ribosomal RNA (rRNA) was removed using the Epicentre Ribo-zero rRNA Removal kit (Illumina, Inc.), according to the manufacturer\'s protocol. Strand-specific sequencing libraries were generated via the dUTP method using the resulting RNA with the NEB Next Ultra Directional RNA Library Prep kit for Illumina (New England BioLabs, Inc., Ipswich, MA, USA), according to the manufacturer\'s protocol. RNA-seq was performed on an Illumina Hiseq 2000 platform (Illumina, Inc.) and 100-bp paired-end reads were generated, according to the manufacturer\'s protocol.

### RNA-seq data analysis

The adapter sequences were removed from the raw sequencing data and the individual libraries were converted to the FASTQ format. Sequence reads were aligned to the human genome (hg19) using TopHat2 (v2.0.9; [ccb.jhu.edu/software/tophat/index.shtml](ccb.jhu.edu/software/tophat/index.shtml)) and the resulting alignment files were reconstructed using Cufflinks (v2.1.1; cole-trapnell-lab.github.io/cufflinks) ([@b12-mmr-17-01-0059]) and Scripture (beta2; [software.broadinstitute.org/software/scripture](software.broadinstitute.org/software/scripture)). The transcripts assembled by Cufflinks and Scripture were used for the identification of differentially expressed genes (DEGs). For mRNA analyses, the RefSeq database (build 37.3; [www.ncbi.nlm.nih.gov/refseq](www.ncbi.nlm.nih.gov/refseq)) was selected for the annotation references. The read counts of each transcript were normalized to the length of the individual transcript and to the total mapped fragment counts in each sample, and expressed as fragments per kilobase of exon per million fragments mapped of mRNAs in each sample. mRNA differential expression analyses were applied to the NRDS and control groups. The P-value was calculated using R3.2.5 software ([www.r-project.org](www.r-project.org)). Adjusted P\<0.05 (Student\'s t-test with Benjamini-Hochberg false discovery rate adjustment) was used as the threshold for significant DEGs. DEGs were analyzed by enrichment analyses to detect over-represented functional terms present in the genomic background. Gene ontology (GO) analysis was performed using the GO-seq package ([bioconductor.org/packages/release/bioc/html/goseq.html](bioconductor.org/packages/release/bioc/html/goseq.html)) in R3.2.5 software, in which gene length bias was corrected. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed using KOBAS 3.0 software ([kobas.cbi.pku.edu.cn](kobas.cbi.pku.edu.cn)).

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

Total RNAs were isolated and quality controlled using protocols from Illumina, Inc. All cDNAs were synthesized using Superscript III (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). The top five over- and underexpressed genes were selected for the RT-qPCR assay. All RT-qPCR primers are presented in [Table II](#tII-mmr-17-01-0059){ref-type="table"}. All qPCR reactions were performed on a Roche Lightcycler 480 PCR system (Roche Applied Science, Penzberg, Germany) using Toyobo Thunderbird SYBR RT-qPCR Mix (Toyobo Life Science, Osaka, Japan), with three technical repeats. The amplification procedure was as follows: 95°C for 5 min, followed by 40 cycles of 95°C for 10 sec and 60°C for 20 sec. Relative quantification of target genes was performed using the 2^−ΔΔCq^ method with GAPDH as a reference gene ([@b13-mmr-17-01-0059]). Pearson correlation was used to calculate the association between RNA sequence and RT-qPCR ([@b14-mmr-17-01-0059]).

Results
=======

### RNA-seq libraries

To replicate the results, control samples were obtained from two patients and NRDS samples from four patients. In total, \>300 million reads were acquired from the six samples. The average percentage of uniquely mapped paired reads was 50.45% and the average GC percentage was 53.7%. Detailed alignment data are presented in [Table III](#tIII-mmr-17-01-0059){ref-type="table"}.

### Identification of DEGs

Compared with the control group, 80 genes were differentially expressed in the NRDS group. Among them, 69 genes were upregulated and 11 were downregulated. [Fig. 1](#f1-mmr-17-01-0059){ref-type="fig"} illustrates all significant DEGs in an MA plot. The top 10 upregulated and downregulated genes (in terms of log~2~FC) are presented in [Table IV](#tIV-mmr-17-01-0059){ref-type="table"}.

In addition, the log2 fold change of 10 genes obtained by RNA-seq and RT-qPCR analysis was compared to validate the DEGs. There was a statistically significant Pearson correlation (R^2^=0.897) between the expression levels measured by RNA-seq and RT-qPCR ([Figs. 2](#f2-mmr-17-01-0059){ref-type="fig"} and [3](#f3-mmr-17-01-0059){ref-type="fig"}).

### GO and KEGG analysis

The mRNA-seq data set comparison to KEGG (12 pathways; [Fig. 4](#f4-mmr-17-01-0059){ref-type="fig"}) and GO (105 gene sets; top 20 presented in [Table V](#tV-mmr-17-01-0059){ref-type="table"}) pathways highlighted the up- and downregulation of three groupings of genes associated with biological function: Cellular processes; innate immune response; and pathogen recognition response. Of the 12 pathways, five of them were associated with immunological mechanisms: The tumor necrosis factor (TNF) signaling pathway ([Fig. 5](#f5-mmr-17-01-0059){ref-type="fig"}); influenza A ([Fig. 6](#f6-mmr-17-01-0059){ref-type="fig"}); leishmaniasis ([Fig. 7](#f7-mmr-17-01-0059){ref-type="fig"}); *Staphylococcus aureus* infection ([Fig. 8](#f8-mmr-17-01-0059){ref-type="fig"}); and tuberculosis ([Fig. 9](#f9-mmr-17-01-0059){ref-type="fig"}). Suppressor of cytokine signaling 3, mitogen-activated protein kinase 14 and major histocompatibility complex II are overexpressed in these pathways; all three of these genes are involved in immune processes.

Within the groupings of cellular processes, the DNA replication and Fanconi anemia pathways were downregulated by 93 and 318 nuclear receptor (NR) genes, respectively, in response to NRDS pathogenesis compared with the control group. By contrast, the cellular proteolysis by ubiquitination and hormone signaling pathways were upregulated by 104 and 82 NR genes, respectively.

Discussion
==========

The phenotype of NRDS is not concluded from a single symptom; rather it is derived from numerous cumulative factors which precipitate NRDS. RNA-seq is an useful tool to illustrate the physiological responses to multiple factors which contribute to the manifestation of NRDS. The following identifies a number of mechanisms observed in the RNA-seq results, which are consistent with those reported in the process of ARDS.

In a case-control study reported by Molnar *et al* ([@b15-mmr-17-01-0059]), increased levels of ubiquitin specific peptidase 10 (USP10) were observed in the ARDS group. In the present study, USP1 was observed to be increased in the NRDS group (data not shown). As USP proteins are involved in autophagy, it may be hypothesized that ARDS and NRDS exhibit similar processes of autophagy.

A recent study by Qiao *et al* ([@b16-mmr-17-01-0059]) illustrated that the ubiquitin-proteasome pathway (UPP) targeted signal transducer and activator of transcription 6 and further regulated T helper cells 2 and 9; this regulation may serve as an ideal target for mitigating the underlying pathology of allergic diseases, particularly asthma. Dysregulation and chronic overexpression of the UPP ligase systems and other ubiquitinated kinase protein components may cause inflammation of the bronchi and promote the pathophysiology of NRDS. Majetschak *et al* ([@b17-mmr-17-01-0059]) demonstrated that ubiquitin-activated 20S core proteasome particles in bronchoalveolar lavage fluid were markedly increased following lung contusions. The proteolytic cleavage of functional proteasome complexes and additional post-protein processing observed within the alveolar space following lung injury may be associated with the pathogenesis of NRDS. It is unknown how cleavage and post-regulation of proteins involved in lung edema clearance interact with essential surfactant proteins, which may further enhance the NRDS pathological cascade.

Inhibition of the ubiquinated protein kinase myristoylated alanine rich protein kinase C substrate (MARCKS) serves a role in mitigating excess pro-inflammatory cytokines release from neutrophils following lipopolysaccharide (LPS) from *Escherichia coli* and the activation of Toll-like receptor (TLR)2, TLR4 and TLR9 ([@b18-mmr-17-01-0059]). The results of this previous study illustrated correct and incorrect post-transcriptional regulation. When organisms were treated with the protein myristoylated N-terminal sequence, an inhibitor of MARCKS, neutrophil migration was mediated; marked alterations were observed in the reduction of mRNA expression associated with LPS-challenged interleukin-8 and TNF-α.

The assessment of various lung cellular responses to numerous environmental factors, by assessing mRNA-seq associated with NRDS, is a viable and sophisticated way to characterize NRDS and ARDS. Assessing the progression of various symptoms towards the onset of diseases may help to further characterize cellular responses associated with disease and to further elucidate the underlying pathogenesis of diseases. A previous study assessed how alterations at the mRNA level affect how transcriptional gene regulation is moderated prior to the production and translation of proteins ([@b15-mmr-17-01-0059]). Gao and Barnes ([@b19-mmr-17-01-0059]) performed a meta-analysis using RNA-seq data of 83 lung-specific genes; only 62 of the genes were required to code for proteins necessary for lung development and pathogenesis. Specifically, in ARDS there are 21 principal genes of interest to target that are associated with the physiological onset of ARDS and similar acute lung injuries.

Due to the hydrophobic nature of surfactants, they are able to keep the alveoli dry and allow for optimal oxygen-blood exchange. Dysregulation of surfactant phospholipids has been previously demonstrated to be associated with alveolar instability and an increased patient risk of developing NRDS ([@b20-mmr-17-01-0059]). Translational regulation of gene families has essential roles in maintaining lung homeostasis, including surfactant-associated proteins (SFTPs; SFTPA1, SFTPA2, SFTPC and SFTPD) which serve a role in understanding the pathology of NRDS ([@b21-mmr-17-01-0059],[@b22-mmr-17-01-0059]).

In a study by D\'Ovidio *et al* ([@b23-mmr-17-01-0059]), clinicians assessed the mortality associated with lung transplants and various mRNA levels among different experimental groups and their surfactant protein polymorphism (SP-A, SP-B, SP-C and SP-D) expression levels. The pilot study demonstrated notable mortality rates in patients; however, those with increased mRNA expression of SP generally exhibited a decreased incidence of allograft rejection by the innate immune system, thus illustrating a marked difference in lung transplant mortality associated with surfactants. Additionally, Silva *et al* ([@b24-mmr-17-01-0059]) observed that the application of the anti-inflammatory agent LASSBio596 may be applied to ARDS mouse models to increase survival rates by mitigating macrophages, neutrophils and transforming growth factor-β by increasing surfactant yield, which in turn reduced surface tension. By maintaining elasticity and surfactant alterations in lung mechanics, the authors were able to counteract degradation immediately following lung injury leading to ARDS.

The removal of surfactant proteins leads to substantial alterations in the alveoli-capillary barrier, leading to the serious phenotype of sepsis. Pathogenesis-induced sepsis of the peripheral lung is denoted by inflammation associated with the presence of the microbial metabolite lactate, which is a standard lung biomarker of sepsis ([@b25-mmr-17-01-0059]). In response to a microbial presence in the form of adhesion or byproducts, the innate immune system is the first to mount a response. In order to further assess the biomarkers of NRDS, Ware *et al* ([@b26-mmr-17-01-0059]) demonstrated that SP-D overexpression is an effective marker of sepsis prognosis; increased expression of this protein from alveolar epithelial type II cells is associated with increased mortality.

In the grouping of gene families associated with the innate immune response, it has been reported that all four pathways, complement and coagulation cascades, tumor TNF signaling, inflammatory bowel disease and prolactin signaling, were upregulated by 50--67 genes in response to NRDS. In the case of pneumonia, pro-inflammatory cytokines and systemic inflammation, the host-associated response will lead to increased TNF expression followed by dysregulation of lung-induced apoptosis by neutrophils ([@b27-mmr-17-01-0059]). Proteinase-activated cascades following lung injury promote the activation of the coagulation response that begins the innate inflammatory response and the additional pro-inflammatory factors, including TNF ([@b28-mmr-17-01-0059]). Macrophage-derived TNF has been demonstrated to further provoke lung injury by stimulating p55 receptor-mediated death signaling; this further exacerbates injury by increasing lung neutrophils and leads to the deleterious phenotype of ARDS ([@b29-mmr-17-01-0059]).

Upstream activation of TNF-α within the lung periphery is an essential mediator of neutrophils, and the pathology of NRDS and ARDS. Plasma TNF-α levels have been observed to be increased in patients with NRDS compared with controls ([@b30-mmr-17-01-0059]). A study performed in mice by Lomas-Neira *et al* ([@b31-mmr-17-01-0059]) demonstrated that the transfer of TNF-α to mice lacking neutrophils did not stimulate the progression of lung injury. By comparison, mice lacking neutrophils expressing TNF-α displayed reduced acute lung injury. These previous results suggested that TNF-α expression in neutrophils is an underlying factor the promotes the progression of the pathogenesis from the initial lung-injury into a shock-primed innate immune response.

In response to colonization by pathogenic organisms, including *Streptococcus pneumoniae*, proteinase-activated receptor 1 serves a role in splicing for the activation of coagulation pathways leading to inflammation; thus, beginning the cascade of neutrophilic pro-inflammatory responses to invasive pathogens, excess neutrophil recruitment contributes to lung injury through alveolar surfactant barrier disruption and alveolar leakage ([@b18-mmr-17-01-0059]).

The pathogen recognition response for NRDS KEGG pathways all had upregulated gene families in the present study; this was the case for all except *Staphylococcus aureus* infection, which was downregulated by 10 NR genes. Upregulated gene families included leishmaniasis, tuberculosis, and influenza A, and the number of genes involved in these three groups were 3, 4 and 3, respectively. Microbial proliferation and sepsis following acute lung injury is a primary contributor to the cascade and severity of NRDS. Lv *et al* ([@b32-mmr-17-01-0059]) demonstrated through transcriptomic analysis that genes associated with foreign pathogens (NLR family pyrin domain containing 3 and S100 calcium binding protein A8/A9) were markedly upregulated in response to microbial LPS.

In addition to sepsis, other factors not involved with the innate immune response or surfactants may contribute to NRDS and ARDS. For example, Lv *et al* ([@b32-mmr-17-01-0059]) demonstrated, through systematic mRNA-seq of ARDS, a significant upregulation of 122 genes and a downregulation of 91 genes associated with essential protein functions, including the mitotic cell cycle. Specifically, the investigators noted that cyclin (CCNB)1 and CCNB2, which serve a role in cell cycle regulation, may be associated with the onset of ARDS.

A previous study of the human microbiome indicated dysbiosis within the human system, typically leading to a dysregulation of host responses to various systemic challenges; in particular, these challenges threaten lung homeostasis and provoke the perpetual inflammation associated with invasive pathogenic microbiota ([@b33-mmr-17-01-0059]). Invasion, persistence and colonization of foreign microbiota challenge the host immune system to further provoke ARDS; the proliferation of microbiota and heightened responses to challenge further provoke the accumulated lung injury to develop into sepsis ([@b34-mmr-17-01-0059]). Infections with and the persistence of numerous viral strains and microbiota, including influenza A ([@b35-mmr-17-01-0059]), *Mycobacterium tuberculosis* ([@b36-mmr-17-01-0059]), *Staphylococcus aureus*/H1N1 strain of the influenza virus ([@b37-mmr-17-01-0059]) and multi-drug resistant *Acinetobacter baumannii* ([@b38-mmr-17-01-0059]).

Dysregulation of TNF and the coagulation cascade pathways may be associated with ubiquitin-mediated kinase activation in the case of proteasome activated lysis, which may activate cascades leading to neutrophil over-stimulation and eventual dysregulated lung damage. In conclusion, the mechanisms leading to a specific NRDS phenotype are complex, although mRNA-seq as a tool may be used to elucidate genomic response to lung-induced stress. Consequently, cascading immune mechanisms associated with the dysregulation of one aspect of the immune response may accumulate progressively towards NRDS.

The present study was supported by the National Natural Science Foundation of China (grant no. gjzr81260107) and the Inner Mongolia Natural Science Foundation (grant no. 2011MS1111).
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###### 

Subject information.

  Sample ID   Sex      Mother   Gestational age, weeks
  ----------- -------- -------- ------------------------
  Control 1   Male     G2P2     38+3
  Control 2   Female   G3P3     38+3
  NRDS1       Male     G2P1     37+6
  NRDS2       Male     G3P1     37+4
  NRDS3       Female   G3P2     37
  NRDS4       Female   G2P1     37+3

G, gravida (the total number of pregnancies); P, para (the total number of deliveries).

###### 

Primers used for RT-qPCR.

  Gene       Primer
  ---------- --------------------------------
  PIP4K2B    Forward: ATTGCACTGGAGACCAGCAA
             Reverse: GTACGCACAAAAGACTGGCG
  FCAR       Forward: GACCACCCTCCTGTGTCTTG
             Reverse: GGATGGAGTCGTAGCACCTG
  MLLT6      Forward: GTGGGCCATGGCAGAAGTAG
             Reverse: CCCTGATTCAAAGCCCCGAA
  DDX52      Forward: TGCGATCAACTACTTCGGCA
             Reverse: ATCGCAGCCATGGACGTTTA
  AC010970   Forward: TGTCAGCACTCCCAACAGAC
             Reverse: GTCCCTCATGGCCACAAGTT
  APBA2      Forward: ACTGGGACCGCTACAGTACA
             Reverse: ATCCAGACTGTCAGCATCGC
  BRD2       Forward: GTCTACCGATTCCCACCTCG
             Reverse: GCCAAGATGGCTGTAGGTGT
  HLA-DQA1   Forward: CTGACAAACATCGCTGTGCT
             Reverse: GAAGCACCAACTGAACGCAG
  MDGA1      Forward: CTCCGAGTACCCCACAGCTA
             Reverse: CATGGATCCCCAAAGTTGCAG
  WASF3      Forward: CTTTTAGGGAACCCGCTGGA
             Reverse: TAGAGCGAACATGGACGACAG
  GAPDH      Forward: TGCACCACCAACTGCTTAGC
             Reverse: GGCATGGACTGTGGTCATGAG

AC010970, AC010970.1; APBA2, amyloid β precursor protein binding family A member 2; BRD2, bromodomain containing 2; DDX52, DExD-box helicase 52; FCAR, Fc fragment of IgA receptor; HLA-DQA1, major histocompatibility complex class II DQ α 1; MDGA1, MAM domain containing glycosylphosphatidylinositol anchor 1; MMLT6, MLLT6 PHD finger containing; PIP4K2B, phosphatidylinositol-5-phosphate 4-kinase type 2 β; WASF3, WAS protein family member 3.

###### 

Results of alignment from RNA sequencing libraries.

  Sample ID   Total reads   Uniquely mapped paired read (%)   Uniquely mapped unpaired read (%)   GC rate, %
  ----------- ------------- --------------------------------- ----------------------------------- ------------
  Control 1   45805780      24193674 (52.8180)                551484 (1.2040)                     55.8
  Control 2   53239568      36388990 (68.3495)                995799 (1.8704)                     48.2
  NRDS1       49799542      19819046 (39.7977)                479564 (0.9630)                     55.7
  NRDS2       53005504      26210282 (49.4482)                573098 (1.0812)                     56.2
  NRDS3       53700026      23724822 (44.1803)                514729 (0.9585)                     56.3
  NRDS4       50728662      24525002 (48.3455)                580637 (1.1446)                     50.1

###### 

Top 10 differentially expressed genes in the neonatal respiratory distress syndrome group compared with the control group.

  Gene            Log~2~FC   P-value        Description
  --------------- ---------- -------------- -------------------------------------------------------------
  Upregulated                               
  PIP4K2B         4.83       1.96×10^−24^   Phosphatidylinositol-5-phosphate 4-kinase type 2β
  FCAR            4.43       5.43×10^−19^   Fc fragment of IgA receptor
  MLLT6           3.87       1.19×10^−13^   PHD finger domain containing
  DDX52           3.52       2.82×10^−11^   DExD-box helicase 52
  AC010970.2      3.09       4.95×10^−10^   AC010970.2
  HBD             2.69       1.49×10^−08^   Hemoglobin subunit δ
  GPR84           2.58       2.65×10^−07^   G protein-coupled receptor 84
  MTRNR2L12       2.47       1.05×10^−07^   MT-RNR2-like 12
  LRRC37A2        2.46       4.07×10^−07^   Leucine rich repeat containing 37 member A2
  Downregulated                             
  APBA2           −3.56      4.91×10^−11^   Amyloid β precursor protein binding family A member 2
  BRD2            −3.19      2.45×10^−13^   Bromodomain containing 2
  HLA-DQA1        −2.61      1.04×10^−06^   Major histocompatibility complex, class II, DQ α 1
  MDGA1           −2.08      1.10×10^−04^   MAM domain containing glycosylphosphatidylinositol anchor 1
  WASF3           −1.94      1.89×10^−04^   WAS protein family member 3
  COL10A1         −1.88      1.84×10^−05^   Collagen type X α 1 chain
  GAN             −1.78      8.67×10^−11^   Gigaxonin
  LRRN3           −1.39      2.48×10^−06^   Leucine rich repeat neuronal 3
  GATA3           −1.36      9.47×10^−05^   GATA binding protein 3
  CSF1R           −1.13      1.4×10^−04^    Colony stimulating factor 1 receptor

###### 

Top 20 enriched GO terms among significantly differentially expressed genes.

  GO ID        Title                                                                 Description                                                                                                                                                                                                                                                              No. of genes   P-value
  ------------ --------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------- ----------
  GO:0006260   DNA replication                                                       The cellular metabolic process in which a cell duplicates one or more molecules of DNA.                                                                                                                                                                                  5              0.000278
  GO:0001878   Response to yeast                                                     Any process that results in a change in state or activity of a cell or an organism as a result of a stimulus from a yeast species.                                                                                                                                       2              0.000873
  GO:0060045   Positive regulation of cardiac muscle cell proliferation              Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.                                                                                                                                                              2              0.001500
  GO:0032094   Response to food                                                      Any process that results in a change in state or activity of a cell or an organism as a result of a food stimulus.                                                                                                                                                       2              0.001750
  GO:0051726   Regulation of cell cycle                                              Any process that modulates the rate or extent of progression through the cell cycle.                                                                                                                                                                                     4              0.001760
  GO:0042246   Tissue regeneration                                                   The regrowth of lost or destroyed tissues.                                                                                                                                                                                                                               2              0.002900
  GO:0042742   Defense response to bacterium                                         Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.                                                                                                                                                                 3              0.003520
  GO:0060333   Interferon-gamma-mediated signaling pathway                           A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process.                                                                                          3              0.004290
  GO:0032201   Telomere maintenance via semi-conservative replication                The process in which telomeric DNA is synthesized semi-conservatively by the conventional replication machinery and telomeric accessory factors as part of cell cycle DNA replication.                                                                                   2              0.005140
  GO:0045003   Double-strand break repair via synthesis-dependent strand annealing   Synthesis-dependent stand annealing is a major mechanism of double-strand break repair in mitosis that allows for the error-free repair of a double-strand break without the exchange of adjacent sequences.                                                             2              0.006020
  GO:0000077   DNA damage checkpoint                                                 A cell cycle checkpoint that regulates progression through the cell cycle in response to DNA damage.                                                                                                                                                                     2              0.006490
  GO:0006513   Protein monoubiquitination                                            Addition of a single ubiquitin group to a protein.                                                                                                                                                                                                                       2              0.006490
  GO:0006953   Acute-phase response                                                  An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.                                                                                               2              0.006490
                                                                                                                                                                                                                                                                                                                                                                             
  GO:0000722   Telomere maintenance via recombination                                Any recombinational process that contributes to the maintenance of proper telomeric length.                                                                                                                                                                              2              0.007460
  GO:0050829   Defense response to Gram-negative bacterium                           Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.                                                                                                                                                   2              0.007970
  GO:0006955   Immune response                                                       Any immune process that functions in the calibrated response of an organism to a potential internal or invasive threat.                                                                                                                                                  5              0.008730
  GO:0097192   Extrinsic apoptotic signaling pathway in absence of ligand            A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell.                                                                                                                                              2              0.011300
  GO:0009408   Response to heat                                                      Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.   2              0.017400
  GO:0032508   DNA duplex unwinding                                                  The process in which interchain hydrogen bonds between two strands of DNA are broken or 'melted', generating a region of unpaired single strands.                                                                                                                        2              0.018100
  GO:0001504   Neurotransmitter uptake                                               The directed movement of neurotransmitters into neurons or glial cells.                                                                                                                                                                                                  1              0.022300

GO, gene ontology.
